Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Bopp, Tobias; Groth, Marie; Winkelmann, Veronika et al.
Tracking the immune response to SARS-CoV-2 mRNA booster vaccination in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s.c. (KYRIOS clinical trial)NEUROLOGY. Bd. 100. H. 17. 2023
Ziemssan, Tjalf; Schlegel, Eugen; Groth, Marie et al.
Tracking the immune response to SARS-CoV-2 mRNA vaccines in ofatumumab treated RMS patients in a multicenter studyMULTIPLE SCLEROSIS JOURNAL. Bd. 29. H. 7. 2023 S. NP34-NP34
Venken, Koen; Decruy, Tine; Sparwasser, Tim et al.
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitisIMMUNOLOGY. 2023
Mello-Vieira, Joao; Bopp, Tobias; Dikic, Ivan
Ubiquitination and cell-autonomous immunityCURRENT OPINION IN IMMUNOLOGY. Bd. 84. 2023
Zipp, Frauke
Uncovering novel RNA molecular targets for clinical traitsMULTIPLE SCLEROSIS JOURNAL. Bd. 29. 2023 S. 38-38
Marti-Juan, Gerard; Sastre-Garriga, Jaume; Martinez-Heras, Eloy et al.
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter studyCEREBRAL CORTEX. Bd. 33. H. 12. 2023 S. 7322-7334
Li, Zhongding; Liu, Baohua; Lambertsen, Kate Lykke et al.
USP25 Inhibits Neuroinflammatory Responses After Cerebral Ischemic Stroke by Deubiquitinating TAB2ADVANCED SCIENCE. 2023
Kavazovi, Inga; Dimitropoulos, Christoforos; Gasparini, Dora et al.
Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cellsCELL REPORTS. Bd. 42. H. 4. 2023
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias et al.
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialBRITISH JOURNAL OF HAEMATOLOGY. Bd. 198. H. 3. 2022 S. 482-491
Birtel, M; Voss, R-H; Reinhard, K et al.
A TCR-like CAR promotes sensitive antigen recognition and controlled T cell expansion upon mRNA vaccinationCancer Res Commun. Bd. 2. H. 8. 2022 S. 827-41